MEK-inhibitor U0126 in hyperglycaemic focal ischaemic brain injury in the rat

European Journal of Clinical Investigation

Volumn 38, Issue 9, 2008, Pages 679-685

  Farrokhnia, N ^a   Ericsson, A ^a   Terent A ^a   Lennmyr, F ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Hyperglycaemia; Magnetic resonance imaging; MAPK; Rat; Reperfusion; Therapeutics

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INFARCTION SIZE; BRAIN INJURY; BRAIN ISCHEMIA; BRAIN PERFUSION; BRAIN PROTECTION; CONTROLLED STUDY; DIFFUSION WEIGHTED IMAGING; DRUG EFFICACY; DRUG INFUSION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; EXPERIMENTAL MODEL; HYPERGLYCEMIA; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NEUROIMAGING; NEUROLOGIC EXAMINATION; NEUROPATHOLOGY; NONHUMAN; PERFUSION WEIGHTED IMAGING; PRIORITY JOURNAL; RAT; RATING SCALE; REPERFUSION; SURVIVAL TIME; TASK PERFORMANCE; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; BRAIN; BRAIN ISCHEMIA; BUTADIENES; ENZYME INHIBITORS; HYPERGLYCEMIA; MAGNETIC RESONANCE IMAGING; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; NITRILES; RATS; RATS, SPRAGUE-DAWLEY; REGIONAL BLOOD FLOW; TREATMENT OUTCOME;

EID: 49749090059     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/j.1365-2362.2008.01990.x     Document Type: Article

References (34)

1. Yip PK, He YY, Hsu CY, Garg N, Marangos P, Hogan EL. Effect of plasma glucose on infarct size in focal cerebral ischaemia-reperfusion. Neurology 1991 41 : 899 905.
2. Ginsberg MD, Prado R, Dietrich WD, Busto R, Watson BD. Hyperglycaemia reduces the extent of cerebral infarction in rats. Stroke 1987 18 : 570 4.
3. Li PA, Shamloo M, Smith ML, Katsura K, Siesjo BK. The influence of plasma glucose concentrations on ischemic brain damage is a threshold function. Neurosci Lett 1994 177 : 63 5.
4. Li PA, He QP, Yi-Bing O, Hu BR, Siesjo BK. Phosphorylation of extracellular signal-regulated kinase after transient cerebral ischemia in hyperglycemic rats. Neurobiol Dis 2001 8 : 127 35.
5. Lennmyr F, Karlsson S, Gerwins P, Ata KA, Terent A. Activation of mitogen-activated protein kinases in experimental cerebral ischemia. Acta Neurol Scand 2002 106 : 333 40.
6. Wu DC, Ye W, Che XM, Yang GY. Activation of mitogen-activated protein kinases after permanent cerebral artery occlusion in mouse brain. J Cereb Blood Flow Metab 2000 20 : 1320 30.
7. Alessandrini A, Namura S, Moskowitz MA, Bonventre JV. MEK1 protein kinase inhibition protects against damage resulting from focal cerebral ischemia. Proc Natl Acad Sci U S A 1999 96 : 12866 9.
8. Namura S, Iihara K, Takami S, Nagata I, Kikuchi H, Matsushita K et al. Intravenous administration of MEK inhibitor U0126 affords brain protection against forebrain ischemia and focal cerebral ischemia. Proc Natl Acad Sci U S A 2001 98 : 11569 74.
9. Farrokhnia N, Roos MW, Terent A, Lennmyr F. Experimental treatment for focal hyperglycemic ischemic brain injury in the rat. Exp Brain Res 2005 167 : 310 4.
10. Farrokhnia N, Roos MW, Terent A, Lennmyr F. Differential early mitogen-activated protein kinase activation in hyperglycemic ischemic brain injury in the rat. European J Clin Invest 2005 35 : 457 63.
11. Longa EZ, Weinstein PR, Carlson S, Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 1989 20 : 84 91.
12. Johansson BB, Ohlsson AL. Environment, social interaction, and physical activity as determinants of functional outcome after cerebral infarction in the rat. Exp Neurol 1996 139 : 322 7.
13. Roos MW, Ericsson A, Berg M, Sperber GO, Sjoquist M, Meyerson BJ. Functional evaluation of cerebral microembolization in the rat. Brain Res 2003 961 : 15 21.
14. Bederson JB, Pitts LH, Tsuji M, Nishimura MC, Davis RL, Bartkowski H. Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination. Stroke 1986 17 : 472 6.
15. Park CK, Mendelow AD, Graham DI, McCulloch J, Teasdale GM. Correlation of triphenyltetrazolium chloride perfusion staining with conventional neurohistology in the detection of early brain ischaemia. Neuropathol Appl Neurobiol 1988 14 : 289 98.
16. Zhang JZ, Jing L, Ma AL, Wang F, Yu X, Wang YL. Hyperglycemia increased brain ischemia injury through extracellular signal-regulated protein Kinase. Pathology, Res Prac 2006 202 : 31 6.
17. He QP, Ding C, Li PA. Effects of hyperglycemic and normoglycemic cerebral ischemia on phosphorylation of c-jun NH2-terminal kinase (JNK) and p38 mitogen-activated protein kinase (MAPK). Cell Mol Biol (Noisy-le-Grand) 2003 49 : 1241 7.
18. Davies SP, Reddy H, Caivano M, Cohen P. Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem J 2000 351 : 95 105.
19. Prado R, Ginsberg MD, Dietrich WD, Watson BD, Busto R. Hyperglycemia increases infarct size in collaterally perfused but not end-arterial vascular territories. J Cereb Blood Flow Metab 1988 8 : 186 92.
20. Cherian L, Hannay HJ, Vagner G, Goodman JC, Contant CF, Robertson CS. Hyperglycemia increases neurological damage and behavioral deficits from post-traumatic secondary ischemic insults. J Neurotrauma 1998 15 : 307 21.
21. Li PA, He QP, Csiszar K, Siesjo BK. Does long-term glucose infusion reduce brain damage after transient cerebral ischemia? Brain Res 2001 912 : 203 5.
22. Smith ML, von Hanwehr R, Siesjo BK. Changes in extra- and intracellular pH in the brain during and following ischemia in hyperglycemic and in moderately hypoglycemic rats. J Cereb Blood Flow Metab 1986 6 : 574 83.
23. Siesjo BK, Siesjo P. Mechanisms of secondary brain injury. Eur J Anaesthesiol 1996 13 : 247 68.
24. Diaz-Parejo P, Stahl N, Xu W, Reinstrup P, Ungerstedt U, Nordstrom CH. Cerebral energy metabolism during transient hyperglycemia in patients with severe brain trauma. Intensive Care Med 2003 29 : 544 50.
25. Sen S, Phillis JW. alpha-Phenyl-tert-butyl-nitrone (PBN) attenuates hydroxyl radical production during ischemia-reperfusion injury of rat brain: an EPR study. Free Radic Res Commun 1993 19 : 255 65.
26. Bonnefont-Rousselot D. Glucose and reactive oxygen species. Curr Opin Clin Nutr Metab Care 2002 5 : 561 8.
27. Li PA, Liu GJ, He QP, Floyd RA, Siesjo BK. Production of hydroxyl free radical by brain tissues in hyperglycemic rats subjected to transient forebrain ischemia. Free Radic Biol Med 1999 27 : 1033 40.
28. Yoshizumi M, Abe J, Haendeler J, Huang Q, Berk BC. Src and Cas mediate JNK activation but not ERK1/2 and p38 kinases by reactive oxygen species. J Biol Chem 2000 275 : 11706 12.
29. Jope RS, Zhang L, Song L. Peroxynitrite modulates the activation of p38 and extracellular regulated kinases in PC12 cells. Arch Biochem Biophys 2000 376 : 365 70.
30. Clausen F, Lundqvist H, Ekmark S, Lewen A, Ebendal T, Hillered L. Oxygen free radical-dependent activation of extracellular signal-regulated kinase mediates apoptosis-like cell death after traumatic brain injury. J Neurotrauma 2004 21 : 1168 82.
31. Zausinger S, Hungerhuber E, Baethmann A, Reulen H, Schmid-Elsaesser R. Neurological impairment in rats after transient middle cerebral artery occlusion: a comparative study under various treatment paradigms. Brain Res 2000 863 : 94 105.
32. Li PA, He QP, Nakamura L, Csiszar K. Free radical spin trap alpha-phenyl-N-tert-butyl-nitron inhibits caspase-3 activation and reduces brain damage following a severe forebrain ischemic injury. Free Radic Biol Med 2001 31 : 1191 7.
33. Scott JF, Robinson GM, French JM, O'Connell JE, Alberti KG, Gray CS. Prevalence of admission hyperglycaemia across clinical subtypes of acute stroke. Lancet 1999 353 : 376 7.
34. Alvarez-Sabin J, Molina CA, Ribo M, Arenillas JF, Montaner J, Huertas R et al. Impact of admission hyperglycemia on stroke outcome after thrombolysis: risk stratification in relation to time to reperfusion. Stroke 2004 35 : 2493 8.